Application of PütterPro 2 in the compression therapy in medical practices - PUETTERPRO 2 2018-01

PAUL HARTMANN AG0 个研究点目标入组 15 人开始时间: 2018年8月24日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Application of PütterPro2 in typical indications within the scope of the specific purpose, inclusion criteria are therefore based essentially on the specifications of the manufacturer in the package insert.
•Patient is maximum 18 years old
•Patient is able to walk without walking frame and has no relevant restrictions in upper ankle
•Patient is willing to use compression therapy according to the physicians prescription during the study period
•Patient was informed about the study and gave written consent to participate in the study.

•The exclusion criteria are also oriented on the specific purpose of the product. In addition, patients cannot be included in the study if:
•the attending physician believes they are not able to understand the nature, significance and consequences of the planned study.
•they have already been treated with PütterPro2 in the two weeks prior to the start of the observational study.
•a pregnancy cannot be ruled out in female patients or if they are breastfeeding.
•An allergy or intolerance of the patient to one or more substances of PütterPro2 is known.

发起方